- Home
- ARBK vs IXHL Comparison
ARBK vs IXHL Comparison
Compare ARBK & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBK
- IXHL
- Stock Information
- Founded
- ARBK 2017
- IXHL 2001
- Country
- ARBK United Kingdom
- IXHL Australia
- Employees
- ARBK N/A
- IXHL N/A
- Industry
- ARBK Finance: Consumer Services
- IXHL
- Sector
- ARBK Finance
- IXHL
- Exchange
- ARBK Nasdaq
- IXHL Nasdaq
- Market Cap
- ARBK 20.1M
- IXHL 20.5M
- IPO Year
- ARBK 2021
- IXHL N/A
- Fundamental
- Price
- ARBK $0.37
- IXHL $0.20
- Analyst Decision
- ARBK Hold
- IXHL
- Analyst Count
- ARBK 1
- IXHL 0
- Target Price
- ARBK N/A
- IXHL N/A
- AVG Volume (30 Days)
- ARBK 252.8K
- IXHL 36.3M
- Earning Date
- ARBK 08-27-2025
- IXHL 05-15-2025
- Dividend Yield
- ARBK N/A
- IXHL N/A
- EPS Growth
- ARBK N/A
- IXHL N/A
- EPS
- ARBK N/A
- IXHL N/A
- Revenue
- ARBK $47,017,000.00
- IXHL $98,000.00
- Revenue This Year
- ARBK $183.90
- IXHL $3,817.06
- Revenue Next Year
- ARBK $26.78
- IXHL $66.67
- P/E Ratio
- ARBK N/A
- IXHL N/A
- Revenue Growth
- ARBK N/A
- IXHL N/A
- 52 Week Low
- ARBK $0.15
- IXHL $0.08
- 52 Week High
- ARBK $1.99
- IXHL $3.13
- Technical
- Relative Strength Index (RSI)
- ARBK 46.08
- IXHL 45.47
- Support Level
- ARBK $0.35
- IXHL $0.20
- Resistance Level
- ARBK $0.39
- IXHL $0.23
- Average True Range (ATR)
- ARBK 0.03
- IXHL 0.02
- MACD
- ARBK -0.00
- IXHL 0.01
- Stochastic Oscillator
- ARBK 22.22
- IXHL 33.30
About ARBK Argo Blockchain plc
Argo Blockchain PLC is a data center business that provides a powerful and efficient platform for cryptocurrency mining operations. The company has operations in strategic locations in North America.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.